Crumly & Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $644K | Sell |
5,993
-1,702
| -22% | -$183K | 0.16% | 81 |
|
|
2025
Q1 | $776K | Sell |
7,695
-1,296
| -14% | -$131K | 0.21% | 68 |
|
|
2024
Q4 | $803K | Sell |
8,991
-72
| -0.8% | -$6.43K | 0.22% | 68 |
|
|
2024
Q3 | $759K | Sell |
9,063
-171
| -2% | -$14.3K | 0.21% | 71 |
|
|
2024
Q2 | $711K | Sell |
9,234
-348
| -4% | -$26.8K | 0.2% | 68 |
|
|
2024
Q1 | $656K | Sell |
9,582
-156
| -2% | -$10.7K | 0.17% | 76 |
|
|
2023
Q4 | $563K | Buy |
9,738
+1,547
| +19% | +$89.4K | 0.16% | 79 |
|
|
2023
Q3 | $432K | Sell |
8,191
-12
| -0.1% | -$634 | 0.17% | 75 |
|
|
2023
Q2 | $444K | Buy |
8,203
+2,695
| +49% | +$146K | 0.18% | 77 |
|
|
2023
Q1 | $276K | Buy |
5,508
+31
| +0.6% | +$1.55K | 0.12% | 95 |
|
|
2022
Q4 | $253K | Buy |
+5,477
| New | +$253K | 0.1% | 84 |
|